Viewing Study NCT00812266


Ignite Creation Date: 2025-12-24 @ 4:41 PM
Ignite Modification Date: 2025-12-25 @ 2:30 PM
Study NCT ID: NCT00812266
Status: TERMINATED
Last Update Posted: 2016-01-26
First Post: 2008-12-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED)
Sponsor: Danish Oncological Lung Cancer Group
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-01
Start Date Type: None
Primary Completion Date: 2013-12
Primary Completion Date Type: ACTUAL
Completion Date: 2015-01
Completion Date Type: ACTUAL
First Submit Date: 2008-12-19
First Submit QC Date: None
Study First Post Date: 2008-12-22
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-01-23
Last Update Post Date: 2016-01-26
Last Update Post Date Type: ESTIMATED